Published in Virol J on June 03, 2011
The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection. PLoS One (2012) 1.38
A review of methods for detect human Papillomavirus infection. Virol J (2012) 1.09
A review of bacteria-animal lateral gene transfer may inform our understanding of diseases like cancer. PLoS Genet (2013) 0.97
Human papilloma virus, DNA methylation and microRNA expression in cervical cancer (Review). Oncol Rep (2014) 0.96
HPV infection: immunological aspects and their utility in future therapy. Infect Dis Obstet Gynecol (2013) 0.89
Blood Groups in Infection and Host Susceptibility. Clin Microbiol Rev (2015) 0.88
Enzymes of the AKR1B and AKR1C Subfamilies and Uterine Diseases. Front Pharmacol (2012) 0.84
The Role of Sexually Transmitted Infections in HIV-1 Progression: A Comprehensive Review of the Literature. J Sex Transm Dis (2013) 0.83
Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer. Oncol Lett (2015) 0.79
Human papillomavirus (HPV) testing on self-collected specimens: perceptions among HIV positive women attending rural and urban clinics in South Africa. Pan Afr Med J (2014) 0.78
High HPV-51 prevalence in invasive cervical cancers: results of a pre-immunization survey in North Sardinia, Italy. PLoS One (2013) 0.78
Activation of Src, Fyn and Yes non-receptor tyrosine kinases in keratinocytes expressing human papillomavirus (HPV) type 16 E7 oncoprotein. Virol J (2013) 0.77
Potential anti-HPV and related cancer agents from marine resources: an overview. Mar Drugs (2014) 0.76
Transcript levels of ten-eleven translocation type 1-3 in cervical cancer and non-cancerous cervical tissues. Oncol Lett (2017) 0.75
Inhibition of antiviral drug cidofovir on proliferation of human papillomavirus-infected cervical cancer cells. Exp Ther Med (2016) 0.75
What do women with gynecologic cancer know about HPV and their individual disease? A pilot study. BMC Cancer (2014) 0.75
High prevalence of co-infection between human papillomavirus (HPV) 51 and 52 in Mexican population. BMC Cancer (2017) 0.75
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade. J Clin Invest (2017) 0.75
Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med (2003) 31.67
The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (1989) 16.54
The causal relation between human papillomavirus and cervical cancer. J Clin Pathol (2002) 14.73
Classification of papillomaviruses. Virology (2004) 14.16
Human papillomavirus and cervical cancer. Lancet (2007) 12.47
Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer (2007) 10.29
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol (2005) 9.67
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet (2004) 8.09
Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet (2006) 7.83
The cervical cancer epidemic that screening has prevented in the UK. Lancet (2004) 7.72
Sexual behaviour in context: a global perspective. Lancet (2006) 7.38
High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br J Cancer (2006) 6.59
Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group. Br J Cancer (1996) 5.24
Estrogen receptors and human disease. J Clin Invest (2006) 4.91
The carcinogenicity of human papillomavirus types reflects viral evolution. Virology (2005) 4.72
Prevalence of HPV infection among men: A systematic review of the literature. J Infect Dis (2006) 4.67
Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem (1996) 4.02
Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis (2005) 3.84
Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis (2002) 3.42
Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR. J Clin Microbiol (2006) 3.34
Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol (1996) 2.94
Immune responses to human papillomavirus. Vaccine (2006) 2.37
Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. CMAJ (2000) 2.12
Haptoglobin genotype and natural fertility in humans. Fertil Steril (1999) 2.05
Incidence, clearance and predictors of human papillomavirus infection in women. CMAJ (2003) 2.04
Haptoglobin, inflammation and disease. Trans R Soc Trop Med Hyg (2008) 1.94
Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins. Cancer Sci (2007) 1.90
Cervical cancer screening programmes and policies in 18 European countries. Br J Cancer (2004) 1.88
Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys. Cancer Epidemiol Biomarkers Prev (2006) 1.77
Natural history of human papillomavirus type 16 virus-like particle antibodies in young women. Cancer Epidemiol Biomarkers Prev (2004) 1.76
Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer (2003) 1.71
Seminal plasma differentially regulates inflammatory cytokine gene expression in human cervical and vaginal epithelial cells. Mol Hum Reprod (2007) 1.67
Human papillomavirus subtype 16 is common in Pakistani women with cervical carcinoma. Int J Infect Dis (2007) 1.64
Interaction of human papillomaviruses with the host immune system: a well evolved relationship. Virology (2008) 1.62
Sensitivity of the cervical transformation zone to estrogen-induced squamous carcinogenesis. Cancer Res (2000) 1.60
Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies. Int J Cancer (2006) 1.57
Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation. J Virol (1995) 1.52
Induction of tetraploidy through loss of p53 and upregulation of Plk1 by human papillomavirus type-16 E6. Oncogene (2006) 1.46
Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands. Int J Cancer (2006) 1.45
Risk factors for HPV DNA detection in middle-aged women. Sex Transm Dis (1997) 1.37
Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs. Int J Cancer (2007) 1.37
Estrogen and ERalpha: culprits in cervical cancer? Trends Endocrinol Metab (2010) 1.33
Sex hormone regulation of in vitro immune response. Estradiol enhances human B cell maturation via inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures. J Exp Med (1981) 1.31
The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation. Proc Natl Acad Sci U S A (2005) 1.31
Haptoglobin genotype modulates the balance of Th1/Th2 cytokines produced by macrophages exposed to free hemoglobin. Atherosclerosis (2006) 1.26
Identification of a novel retinoblastoma gene product binding site on human papillomavirus type 16 E7 protein. J Biol Chem (1994) 1.21
Haptoglobin polymorphisms and iron homeostasis in health and in disease. Clin Chim Acta (2004) 1.18
Tissue-spanning redox gradient-dependent assembly of native human papillomavirus type 16 virions. J Virol (2009) 1.18
Proteasomal degradation of the papillomavirus E2 protein is inhibited by overexpression of bromodomain-containing protein 4. J Virol (2009) 1.13
Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness. Eur J Cancer (2000) 1.12
Interferon-beta treatment of cervical keratinocytes naturally infected with human papillomavirus 16 episomes promotes rapid reduction in episome numbers and emergence of latent integrants. Carcinogenesis (2006) 1.11
Risk factors for human papillomavirus exposure and co-factors for cervical cancer in Latin America and the Caribbean. Vaccine (2008) 1.11
A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus. Cancer Epidemiol Biomarkers Prev (2004) 1.08
Chronic inflammation, immunosuppression and cancer: new insights and outlook. Semin Cancer Biol (2006) 1.08
New technologies in cervical cytology screening: a word of caution. Obstet Gynecol (1999) 1.07
Sexual behaviour and HPV infections in 18 to 29 year old women in the pre-vaccine era in the Netherlands. PLoS One (2008) 1.04
Determinants of seropositivity among HPV-16/18 DNA positive young women. BMC Infect Dis (2010) 1.03
Relationship between steroid hormone contraceptives and HPV, cervical intraepithelial neoplasia and cervical carcinoma. Int J Cancer (2003) 1.01
Regulation of dendritic cells by female sex steroids: relevance to immunity and autoimmunity. Autoimmunity (2007) 1.01
The biochemical and biological functions of human papillomavirus type 16 E5 protein. Arch Virol (2003) 1.00
The E8--E2 gene product of human papillomavirus type 16 represses early transcription and replication but is dispensable for viral plasmid persistence in keratinocytes. J Virol (2008) 0.99
Epidemiologic risk profile of infection with different groups of human papillomaviruses. J Med Virol (2009) 0.95
The E6 protein of the cutaneous human papillomavirus type 8 can stimulate the viral early and late promoters by distinct mechanisms. J Virol (2006) 0.94
Immunosuppressive mechanisms in semen: implications for contraception. Hum Reprod (1995) 0.93
High expression of PGE2 enzymatic pathways in cervical (pre)neoplastic lesions and functional consequences for antigen-presenting cells. Cancer Immunol Immunother (2008) 0.92
Missed opportunities for cervical cancer screening of HMO members developing invasive cervical cancer (ICC). Gynecol Oncol (1998) 0.90
Human papillomavirus E7 requires the protease calpain to degrade the retinoblastoma protein. J Biol Chem (2007) 0.88
Cervical cancer screening programme in Finland with an example on implementing alternative screening methods. Coll Antropol (2007) 0.85
Seminal plasma activates cyclooxygenase-2 and prostaglandin E2 receptor expression and signalling in cervical adenocarcinoma cells. Mol Hum Reprod (2002) 0.85
High-risk HPV E5-induced cell fusion: a critical initiating event in the early stage of HPV-associated cervical cancer. Virol J (2010) 0.83
Reducing patient risk for human papillomavirus infection and cervical cancer. J Am Osteopath Assoc (2008) 0.81
Effects of environmental tobacco smoke in vivo on rhesus monkey semen quality, sperm function, and sperm metabolism. Reprod Toxicol (2008) 0.77
Determinants of human papillomavirus types 16 and 18 infections in the lower female genital tract in an Italian population. Eur J Gynaecol Oncol (1994) 0.76
Pattern and molecular epidemiology of Hepatitis B virus genotypes circulating in Pakistan. Infect Genet Evol (2010) 1.61
Correlation of biochemical markers and HCV RNA titers with fibrosis stages and grades in chronic HCV-3a patients. Eur J Gastroenterol Hepatol (2014) 1.38
Hepatitis associated aplastic anemia: a review. Virol J (2011) 1.32
Hepatitis C treatment: current and future perspectives. Virol J (2010) 1.32
The changing epidemiology pattern and frequency distribution of hepatitis C virus in Pakistan. Infect Genet Evol (2010) 1.18
Avian influenza A (H9N2): computational molecular analysis and phylogenetic characterization of viral surface proteins isolated between 1997 and 2009 from the human population. Virol J (2010) 1.17
Molecular epidemiology of Hepatitis C virus genotypes in Khyber Pakhtoonkhaw of Pakistan. Virol J (2010) 1.15
Serotype and genotype analysis of dengue virus by sequencing followed by phylogenetic analysis using samples from three mini outbreaks-2007-2009 in Pakistan. BMC Microbiol (2011) 1.11
Hepatitis C virus genotypes circulating in district Swat of Khyber Pakhtoonkhaw, Pakistan. Virol J (2011) 1.06
Hepatitis B virus in Pakistan: a systematic review of prevalence, risk factors, awareness status and genotypes. Virol J (2011) 1.02
Prevalence of active hepatitis c virus infection in district Mansehra Pakistan. Virol J (2010) 1.02
Hepatitis C virus genotype 3a with phylogenetically distinct origin is circulating in Pakistan. Genet Vaccines Ther (2011) 0.98
PCR could be a method of choice for identification of both pulmonary and extra-pulmonary tuberculosis. BMC Res Notes (2011) 0.97
True prevalence of twin HDV-HBV infection in Pakistan: a molecular approach. Virol J (2011) 0.95
Promiscuous prediction and conservancy analysis of CTL binding epitopes of HCV 3a viral proteome from Punjab Pakistan: an in silico approach. Virol J (2011) 0.93
Determination of HCV genotypes and viral loads in chronic HCV infected patients of Hazara Pakistan. Virol J (2011) 0.91
High baseline interleukine-8 level is an independent risk factor for the achievement of sustained virological response in chronic HCV patients. Infect Genet Evol (2011) 0.90
Effects of host and virus related factors on interferon-α+ribavirin and pegylated-interferon+ribavirin treatment outcomes in chronic Hepatitis C patients. Virol J (2011) 0.88
Comparative sequence, antigenic and phylogenetic analysis of avian influenza (H9N2) surface proteins isolated in Pakistan between 1999 and 2008. J Infect Dev Ctries (2011) 0.86
Spontaneous resolution of inflammatory myofibroblastic tumor of the kidney. Can J Urol (2014) 0.86
In vitro chemoresistance testing in well-differentiated carcinoid tumors. Ann Surg Oncol (2009) 0.85
(2R)-2-Benzene-sulfonamido-2-phenyl-ethanoic acid: a new monoclinic polymorph. Acta Crystallogr Sect E Struct Rep Online (2009) 0.84
Urachal malignant fibrous histiocytoma: a case report and review of the literature. Arch Pathol Lab Med (2004) 0.83
Determination of hepatitis C virus genotypes circulating in different districts of Punjab (Pakistan). Eur J Gastroenterol Hepatol (2014) 0.83
The first complete genome sequence of HCV-1a from Pakistan and a phylogenetic analysis with complete genomes from the rest of the world. Virol J (2013) 0.82
Expression of core antigen of HCV genotype 3a and its evaluation as screening agent for HCV infection in Pakistan. Virol J (2011) 0.82
Sarcomatoid carcinoma after radiation treatment of prostatic adenocarcinoma. Ann Diagn Pathol (2007) 0.81
Hepatitis G virus associated aplastic anemia: a recent case from Pakistan. Virol J (2011) 0.81
Seroepidemiology of dengue fever in Khyber Pakhtunkhawa, Pakistan. Int J Infect Dis (2013) 0.81
Envelope 2 protein phosphorylation sites S75 & 277 of hepatitis C virus genotype 1a and interferon resistance: a sequence alignment approach. Virol J (2011) 0.80
Hepatitis E virus-associated aplastic anaemia: the first case of its kind. J Clin Virol (2012) 0.80
Simultaneous amplification of two bacterial genes: more reliable method of Helicobacter pylori detection in microbial rich dental plaque samples. Curr Microbiol (2010) 0.80
Cytoplasmic staining of OCT4 is a highly sensitive marker of adrenal medullary-derived tissue. Am J Surg Pathol (2013) 0.80
Computational identification of interplay between phosphorylation and O-β-glycosylation of human occludin as potential mechanism to impair hepatitis C virus entry. Infect Genet Evol (2012) 0.80
The prevalence of HBV infection in the cohort of IDPs of war against terrorism in Malakand Division of Northern Pakistan. BMC Infect Dis (2011) 0.80
Computational identification and modeling of crosstalk between phosphorylation, O-β-glycosylation and methylation of FoxO3 and implications for cancer therapeutics. Int J Mol Sci (2012) 0.79
A comparison of the effect of glitazones on serum sialic acid in patients with type 2 diabetes. Diab Vasc Dis Res (2011) 0.78
Role of CT scan in the diagnosis of brain infections. J Ayub Med Coll Abbottabad (2002) 0.78
Mutations in the E2-PePHD region of hepatitis C virus genotype-3a and correlation with response to interferon and ribavirin combination therapy in Pakistani patients. Virol J (2010) 0.78
Mutations in the NS5A gene are associated with response to interferon+ribavirin combination therapy in patients with chronic hepatitis C virus 3a infection. Eur J Gastroenterol Hepatol (2013) 0.78
Helicobacter pylori in dental plaque; is it related to brushing frequency, plaque load and oral health status? J Coll Physicians Surg Pak (2011) 0.78
Identification of ionotrophic purinergic receptors in Huh-7 cells and their response towards structural proteins of HCV genotype 3a. Virol J (2011) 0.78
Prevalence of hepatitis delta virus infection among hepatitis B virus surface antigen positive patients circulating in the largest province of Pakistan. Virol J (2010) 0.78
Mycoplasma genitalium: a comparative genomics study of metabolic pathways for the identification of drug and vaccine targets. Infect Genet Evol (2011) 0.78
Association of hepatitis C virus with insulin resistance: evidences from animal studies and clinical studies. Hepat Mon (2012) 0.77
Response to combination therapy of HCV 3a infected Pakistani patients and the role of NS5A protein. Virol J (2011) 0.77
Frequency of hepatitis C in asymptomatic patients in District Headquarters Hospital Kotli, Azad Kashmir. J Ayub Med Coll Abbottabad (2014) 0.77
An overview of treatment response rates to various anti-viral drugs in Pakistani hepatitis B virus infected patients. Virol J (2011) 0.77
Prevalence of HBV infection in suspected population of conflict-affected area of war against terrorism in North Waziristan FATA Pakistan. Infect Genet Evol (2012) 0.77
Emergence of genetically variant Hepatitis C virus population in response to increased antiviral drug pressure, Pakistan. Virus Genes (2014) 0.76
Mixed genotype infections with hepatitis C virus, Pakistan. Emerg Infect Dis (2011) 0.76
Hepatitis delta virus genotype-1 alone cocirculates with hepatitis B virus genotypes A and D in Pakistan. Eur J Gastroenterol Hepatol (2014) 0.76
Development of Global Consensus of Dengue Virus Envelope Glycoprotein for Epitopes Based Vaccine Design. Curr Comput Aided Drug Des (2015) 0.76
Characterization of hepatitis C Virus genotype 3a hypervariable region 1 in patients achieved rapid virological response to alpha interferon and ribavirin combination therapy. Virol J (2011) 0.75
A systematic review of treatment response rates in Pakistani hepatitis C virus patients; current prospects and future challenges. Medicine (Baltimore) (2016) 0.75
Bladder diverticulum: clinicopathologic spectrum in pediatric patients. Pediatr Dev Pathol (2012) 0.75
Isolation and characterization of two new hepatitis E virus genotype 1 strains from two mini-outbreaks in Lahore, Pakistan. Virol J (2011) 0.75
Papanicolaou stain may not be necessary in majority of head and neck fine-needle aspirations: evidence from a correlation study between Diff-Quik-based onsite diagnosis and final diagnosis in 287 head and neck fine-needle aspirations. Diagn Cytopathol (2010) 0.75
Frequency of hepatitis B in asymptomatic patients of District Headquarter Hospital Kotli, Azad Kashmir. J Ayub Med Coll Abbottabad (2012) 0.75
Emerging Viral Infections in Pakistan: Issues, Concerns, and Future Prospects. Health Secur (2017) 0.75
Studies on the role of neutralizing antibodies against envelope genes in resolving HCV pseudo-particles infection. Mol Biol Rep (2014) 0.75
Generation of infectious HCV pseudo typed particles and its utilization for studying the role of CD81 & SRBI receptors in HCV infection. Mol Biol Rep (2014) 0.75
Evaluation of Pro-C global for identification of defects in protein C/S anticoagulant pathway. J Ayub Med Coll Abbottabad (2012) 0.75
Rising relapse rate in hepatitis C virus type 3a-infected patients against sofosbuvir and ribavirin combination therapy: a Pakistani experience. Eur J Gastroenterol Hepatol (2017) 0.75
Frequency and severity of neutropenia in diffuse large B-cell non Hodgkin's lymphoma after first cycle of chemotherapy comprising cyclophosphamide, doxorubicin, vincristine with prednisolone. J Ayub Med Coll Abbottabad (2012) 0.75
Fine-Needle Aspiration of Metastatic Central Type Primitive Neuroectodermal Tumors in Patients with a Germ Cell Tumor. Acta Cytol (2017) 0.75
Erratum: Towards peptide vaccines against Zika virus: Immunoinformatics combined with molecular dynamics simulations to predict antigenic epitopes of Zika viral proteins. Sci Rep (2017) 0.75